50.28 USD
+1.13
2.3%
At close Updated Nov 25, 4:00 PM EST
Pre-market
After hours
50.03
-0.25
0.5%
1 day
2.3%
5 days
-0.22%
1 month
-2.2%
3 months
0.3%
6 months
-4.03%
Year to date
4.34%
1 year
3.99%
5 years
0.16%
10 years
13.63%
 

About: Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Employees: 82,878

0
Funds holding %
of 7,472 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 11 articles
Price charts implemented using Lightweight Charts™